Compared with clopidogrel, ticagrelor has a more significant improvement effect on platelet aggregation status in ACS patients, and its clinical efficacy is significantly better than the former.
Compared with clopidogrel, the improved platelet aggregation in ACS patients was more significant, and its clinical efficacy was significantly better than that of the former.
Compared with clopidogrel, tegrarol has more significant effect on improving platelet aggregation in ACS patients, and its clinical effect is significantly better than the former.<br>